Condition: Gastroesophageal Reflux Disease · Sponsor: Qilu Hospital of Shandong University
The study objective is to evaluate the relative merits, safety and effectiveness of Anti-reflux mucosal valvuloplasty (ARMV) in GERD patients currently treated with daily Proton Pump Inhibitors (PPIs).
This description comes directly from the study's public registry record.
jiaoyang j lu · 18560089069 · lujiaoyang@sdu.edu.cn
Always discuss trial participation with your own doctor first.
| Qilu Hospital of Shandong University, Department of Gastroenterology and Endoscopy Center | Jinan, Shandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06348420